Ex vivo treatment of murine splenocyte-supplemented bone marrow inocula with mafosfamide prior to allogeneic transplantation in an attempt to prevent lethal graft-versus-host disease without compromising engraftment.

Source:http://linkedlifedata.com/resource/pubmed/id/3058776

Download in:

View as

General Info

PMID
3058776